<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojmm
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Medical Microbiology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2165-3372
   </issn>
   <issn publication-format="print">
    2165-3380
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojmm.2025.153013
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojmm-145609
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Phenotypic Characterization of Antibiotic Resistance in Escherichia coli Strains Isolated from Bovine Faeces in the District of Abidjan
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Félicité
      </surname>
      <given-names>
       Beudjé
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Valérie Carole M’Bengue
      </surname>
      <given-names>
       Gbonon
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Fernique
      </surname>
      <given-names>
       Konan
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Bertin
      </surname>
      <given-names>
       Tiekoura
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jean Paul N’Gbesso
      </surname>
      <given-names>
       N’Gbesso
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Sidjé Arlette
      </surname>
      <given-names>
       Afran
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Kouadio Nathalie
      </surname>
      <given-names>
       Guessennd
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aAntibiotics, Natural Substances and Surveillance of Microorganisms for Anti-Infectives Unit (ASSURMI), National Reference Center for Antimicrobial Resistance (CNR/RAM), Institut Pasteur de Côte d’Ivoire, Abidjan, Côte d’Ivoire
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aLaboratory of Biotechnology, Agriculture, and Valorization of Biological Resources, Faculty of Biosciences, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     03
    </day> 
    <month>
     09
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    03
   </issue>
   <fpage>
    167
   </fpage>
   <lpage>
    179
   </lpage>
   <history>
    <date date-type="received">
     <day>
      1,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      12,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      12,
     </day>
     <month>
      September
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Meat of bovine origin is one of the main vectors for the transmission of Escherichia coli to human consumers. This pathogen can cause serious human illness. 
    <b>Objective: </b>The objective of this study was to characterize the resistance phenotype of Escherichia coli isolates isolated from bovine dung in the Abidjan district. 
    <b>Methods</b>: A total of 336 cattle dung samples were analyzed and 23.80% (80/336) were positive for Escherichia coli. 
    <b>Results</b>: The most common phenotypic resistances detected were 42.9% for nalidixic acid, 33.3% for amoxicillin, 30% for amoxicillin/clavulanic acid, 25% for enrofloxacin, 20% respectively for cefepime and trimethoprim-sulfamethoxazole. However, no resistance was observed to ticarcillin, ceftazidime, gentamicin and amikacin. In total, 70% (56/80) of isolates were resistant to at least three (3) antibiotic families, and 20% (16/80) were resistant to at least four (4) families. These results suggest that Escherichia coli isolates from bovine faeces are significantly diverse in terms of antibiotic resistance. 
    <b>Conclusion</b>: the gastrointestinal microflora of cattle could be an important reservoir of various determinants of antimicrobial resistance, which is potentially dangerous for public health.
   </abstract>
   <kwd-group> 
    <kwd>
     Escherichia coli
    </kwd> 
    <kwd>
      Antibiotics
    </kwd> 
    <kwd>
      Resistance
    </kwd> 
    <kwd>
      Bovine
    </kwd> 
    <kwd>
      Côte d’Ivoire
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>
    <xref ref-type="bibr" rid="scirp.145609-"></xref>Ruminant farming in Côte d’Ivoire is underdeveloped and the country remains dependent on neighbouring countries such as Mali and Burkina Faso for its supplies. In large urban cities, beef is the source of animal protein <xref ref-type="bibr" rid="scirp.145609-">
     [
    </xref><xref ref-type="bibr" rid="scirp.145609-1">
     1]
    </xref> and therefore occupies an important place in the daily diet of the population. This situation has led to the appearance of local livestock farming, also known as urban and peri-urban livestock farming, which supplies the livestock market and slaughterhouses. In the district of Abidjan, the breeding of these ruminants contributes to the fight against food insecurity, by supplying slaughterhouses and creating jobs <xref ref-type="bibr" rid="scirp.145609-1">
     [1]
    </xref>. In addition, this type of urban livestock farming represents an important source of income for the population and contributes greatly to the fight against poverty <xref ref-type="bibr" rid="scirp.145609-2">
     [2]
    </xref>, <xref ref-type="bibr" rid="scirp.145609-3">
     [3]
    </xref>. The excrement of these animals is generally used as fertilizer for vegetable crops in cities <xref ref-type="bibr" rid="scirp.145609-1">
     [1]
    </xref> making the animal sector a risk to public health.</p>
   <p>The bacterium Escherichia coli is a bacterial species mainly present in the digestive tract of humans and animals in a commensal manner, but it can also be pathogenic.</p>
   <p>The Enterobacteriaceae family is commonly used as an indicator of fecal contamination during microbiological analyses of food. It includes important zoonotic bacteria such as Salmonella spp.,Yersinia spp. and Escherichia coli, Klebsiella spp. Enterobacteriaceae are important causes of serious infections, and many of their most important members are becoming increasingly resistant to currently available antimicrobials <xref ref-type="bibr" rid="scirp.145609-4">
     [4]
    </xref>.</p>
   <p>In fact, cattle can also harbour antibiotic-resistant Escherichia coli strains. These strains of pathogenic Escherichia coli and/or antibiotic-resistant foods can be transmitted to humans either through direct contact with cattle or indirectly through the ingestion of raw or undercooked bovine feed, but also through the environment. Hence the importance of considering, in a One Health context, that antibiotic resistance in environments impacted by cattle represents a major health issue <xref ref-type="bibr" rid="scirp.145609-1">
     [1]
    </xref>. The indiscriminate use of antibiotics in animals and especially in cattle to promote growth and prevent disease is directly linked to the incidence of resistant bacteria in their resident microbiota <xref ref-type="bibr" rid="scirp.145609-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.145609-6">
     [6]
    </xref> that could potentially contaminate the carcass during the slaughter process or subsequent handling and be transmitted to consumers and distributed in the environment <xref ref-type="bibr" rid="scirp.145609-7">
     [7]
    </xref> <xref ref-type="bibr" rid="scirp.145609-8">
     [8]
    </xref>.</p>
   <p>This antibiotic resistance is currently one of the greatest threats to health, food security and development in the world. Resistance to ampicillin (92.5%), tetracycline (76.6%) and trimethoprim/sulfamethoxazole (70.1%), 51.9% to sulfamethoprim, 26.9% to neomycin and 9.6% to enrofloxacin has been reported <xref ref-type="bibr" rid="scirp.145609-9">
     [9]
    </xref>. The epidemiological evolution of resistant pathogenic bacteria around the world is a warning of a potential danger for food safety.</p>
   <p>Unfortunately, in Côte d’Ivoire, apart from the work of Yao <xref ref-type="bibr" rid="scirp.145609-1">
     [1]
    </xref>, there are very few data on cattle farming in the development of antibiotic resistance and its possible transfer to humans.</p>
   <p>In this study, the objective was to determine the level of resistance of Escherichia coli strains isolated from bovine dung on a cattle farm in the district of Abidjan.</p>
  </sec><sec id="s2">
   <title>2. Material and Methods</title>
   <sec id="s2_1">
    <title>2.1. Material</title>
    <p>Study Area</p>
    <p>
     <xref ref-type="bibr" rid="scirp.145609-"></xref>Samples were collected in four communes in the district of Abidjan (Abobo, Adjamé, Yopougon and Bingerville) and in the commune of Jacqueville located in the district of Lagunes. The district of Abidjan located at 5˚20'00'' N, 4˚01'00'' W is composed of 13 communes that extend over 2119 km<sup>2</sup>; it is the most populous city in French-speaking West Africa with more than 6.321 million inhabitants <xref ref-type="bibr" rid="scirp.145609-10">
      [10]
     </xref>.</p>
    <p>The commune of Jacqueville, whose geographical coordinates are 5˚12'0" N and 4˚30'0" W, is a city located in the south of Côte d’Ivoire, about 60 km from the Abidjan agglomeration, in the Grands-Ponts region. Its population is estimated at 49,694 <xref ref-type="bibr" rid="scirp.145609-10">
      [10]
     </xref>. These municipalities were selected for the presence of many types of livestock (poultry, cattle, rabbits) and the agreement of the owners of the farms to participate in the study. Parks are individual but usually community parks with cattle owned by several owners.</p>
    <p>The study area has two rainy seasons and two dry seasons <xref ref-type="bibr" rid="scirp.145609-11">
      [11]
     </xref>. It is characterized by abundant rainfall (1500 mm of water/year) and an average temperature of 27˚C and the average annual humidity level is more than 80%.</p>
    <p>Collection sites</p>
    <p>Collection sites were recruited on the basis of the presence of groups of animals in cattle pens belonging to either a single individual or several owners and the agreement of the breeders to participate in the study. In each municipality visited, it was necessary to explain the objectives of this study in order to obtain the agreement of the park owner(s) to participate in the study. Then, each park representing an epidemiological unit was selected on the basis of an estimated population of 50 to 100 head of adult beef cattle intended for sale for the consumption of local populations.</p>
    <p>Type and period of study</p>
    <p>This is a descriptive cross-sectional study that took place over a six-month period from January to June 2024. Microbiological analyses were carried out at the National Reference Center for Antibiotics at the Institut Pasteur de Côte d’Ivoire, Adiopodoumé site. The antibiotic susceptibility test was carried out at the Antibiotics, Natural Substances and Microorganism Surveillance to Anti-Infectives Unit of the Institut Pasteur de Côte d’Ivoire, Cocody site.</p>
    <p>Study population</p>
    <p>The study population consisted of beef cattle herds intended for human consumption, consisting mainly of adult cattle of the Zebu breed.</p>
    <p>Inclusion criteria</p>
    <p>The study involved adult cattle between 2 and 4 years of age, apparently healthy, i.e. without observable pathological signs and awaiting slaughter for sale for human consumption.</p>
    <p>Young animals less than two years of age, sick animals and those undergoing treatment were not included in this study.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Methods</title>
    <p>Sampling</p>
    <p>In each park visited, approximately 5 to 10 apparently healthy cattle were selected based on the estimated number of cattle on a random basis. Using long, sterile gloves, a quantity of about 100 grams of faeces was collected directly from the rectum of the animals and put in sterile collection jars. The samples collected were immediately placed in a cooler containing cold accumulators and then transported to the laboratory of the National Reference Center for Antibiotic Resistance (CNR/RAM) of the Institut Pasteur de Côte d’Ivoire, Adiopodoumé site.</p>
    <p>Collection form</p>
    <p>A collection sheet was used to collect field data on the parks and animals. This information concerned: general data on the park (collection location, type of farming, information on the owner(s), animal data (animal species, breed, estimated number of animals) and treatments administered (current treatments, commonly used medications).</p>
    <p>Surveys</p>
    <p>The surveys were carried out in parallel with the collection of samples. A pre-established questionnaire was administered to individual breeders on the geographical location of the park or farm, the owners, the different breeds and numbers of animals, the diseases commonly observed, the treatments administered with particular emphasis on the antibiotic molecules used during the last 10 days prior to the visit. Ongoing treatment during the visit was a criterion for excluding animals from the study.</p>
    <p>Sample transport</p>
    <p>The samples were transported in a cooler with cold packs to the laboratory of the National Reference Center for Antimicrobial Resistance (CNR-RAM) at the Institut Pasteur de Côte d’Ivoire (Adiopodoumé site).</p>
    <p>Isolation and identification</p>
    <p>Approximately 25 g of fecal sample was dissolved in 225 mL of buffered peptone water (BPW) and incubated for 24 hours at 37˚C. The next day, the broth was isolated using the streak method on an Eosin Methylene Blue (EMB) agar and pure cultures of the isolates were obtained after 24 hours of incubation at 37˚C. All colonies with a suspicious typical metallic reflection on EMB were subjected to morphological and biochemical tests using conventional bacteriological methods.</p>
    <p>Antibiotic Susceptibility Testing</p>
    <p>The antibiotic susceptibility test was carried out in accordance with the EUCAST-CASFM version 2023 standard.</p>
    <p>From a 24-hour pure bacterial culture on ordinary agar, 2 to 3 colonies were taken from the loop and emulsified in 2 ml of saline water (0.85% NaCl, BioMérieux®, France) to obtain a turbidity of 0.5 on the MacFarland scale, which corresponds to a bacterial concentration of 10<sup>6</sup> CFU/ml.</p>
    <p>Kirby Bauer’s modified WHO-recommended method based on diffusion from antibiotic-impregnated discs on Muller-Hinton agar <xref ref-type="bibr" rid="scirp.145609-12">
      [12]
     </xref> was used to perform the antibiotic susceptibility test. Help sterile swab sticks soaked in the bacterial suspension, each isolate was inoculated with tight streaks over the entire surface of the Müller-Hinton agar. The inoculum should be evenly distributed over the entire surface of the agar, taking care not to leave any space between the streaks. A panel of twelve antibiotic discs (Bio Mérieux France) including: amoxicillin (20 μg), amoxicillin-clavulanic acid (20/10 μg), ticarcillin (75 μg), cefoxitin (30 μg), ceftazidime (30 μg), cefepime (30 μg), gentamicin (10 μg), amikacin (30 μg) trimethoprim-sulfamethoxazole (25 μg), tetracycline (30 μg), nalidixic acid (30 μg), enrofloxacin (5 μg) were used in the study. For sensitivity testing, a Reference strain Escherichia coli ATCC25922 was used as an internal quality control for antibiotic susceptibility testing.</p>
    <p>After incubation, the reading and interpretation of the results was done using BioRad’s ADAGIO® automatic reader (BIORAD France).</p>
    <p>Detection of the ESBL phenotype according to the double synergy test</p>
    <p>All strains of Escherichia coli isolated cells were detected for the production of extended-spectrum beta-lactamase by the double diffusion or double synergy assay. It is conducted under the standard conditions of the antibiogram. Ceftazidime and cefepime discs were placed around an amoxicillin/clavulanic acid disc on Müller-Hinton agar (approximately 15 mm) and then incubated at 37˚C for 24 hours. The appearance of an image in the shape of a champagne cork reflects the production of an extended-spectrum beta-lactamase by the strain of Escherichia coli tested <xref ref-type="bibr" rid="scirp.145609-13">
      [13]
     </xref>.</p>
    <p>Statistical analyses</p>
    <p>All the qualitative variables were described by frequencies and percentages using the “Excel” tool.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <p>During the study period, 34 cattle yards were visited, three (3) of which were excluded due to ongoing treatment for pathological problems.</p>
   <sec id="s3_1">
    <title>3.1. Sampling</title>
    <p>During the study period, a total of 336 samples were collected in the various parks selected. The distribution of the samples according to the municipalities is summarized in <xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>.</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. Prevalence of Detected E coli Strains</title>
    <p>The analysis of the results revealed the presence of Escherichia coli strains in the faeces of cattle in all the parks recruited. Thus, out of a total of 336 cattle samples taken, 80 strains of Escherichia coli were identified (<xref ref-type="table" rid="table1">
      Table 1
     </xref>), i.e. a prevalence of 23.80%.</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. Antibiotic Susceptibility of Strains</title>
    <p>The antibiotic resistance study showed that Escherichia coli strains had high rates of resistance to commonly used antibiotics such as nalidixic acid (42.9%), amoxicillin (33.3%), amoxicillin/clavulanic acid (30%), enrofloxacin (25%), cefepime (20%) and trimethoprim-sulfamethoxazole (20%). These strains showed no resistance to ticarcillin, ceftazidime, gentamicin and amikacin (see <xref ref-type="fig" rid="fig2">
      Figure 2
     </xref> below).</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.145609-"></xref>Figure 1. Distribution of samples collected according to municipalities.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2260702-rId13.jpeg?20250915043359" />
    </fig>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.145609-"></xref>Table 1. Distribution of Escherichia coli strains isolated according to the municipalities.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="33.87%"><p style="text-align:center">COMMON</p></td> 
       <td class="custom-bottom-td acenter" width="33.24%"><p style="text-align:center">Number (n)</p></td> 
       <td class="custom-bottom-td acenter" width="32.89%"><p style="text-align:center">Percentages (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="33.87%"><p style="text-align:center">Adjamé</p></td> 
       <td class="custom-top-td acenter" width="33.24%"><p style="text-align:center">16</p></td> 
       <td class="custom-top-td acenter" width="32.89%"><p style="text-align:center">20</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.87%"><p style="text-align:center">Yopougon</p></td> 
       <td class="acenter" width="33.24%"><p style="text-align:center">24</p></td> 
       <td class="acenter" width="32.89%"><p style="text-align:center">30</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.87%"><p style="text-align:center">Bingerville</p></td> 
       <td class="acenter" width="33.24%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="32.89%"><p style="text-align:center">10</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.87%"><p style="text-align:center">Abobo</p></td> 
       <td class="acenter" width="33.24%"><p style="text-align:center">16</p></td> 
       <td class="acenter" width="32.89%"><p style="text-align:center">20</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.87%"><p style="text-align:center">Jacqueville</p></td> 
       <td class="acenter" width="33.24%"><p style="text-align:center">16</p></td> 
       <td class="acenter" width="32.89%"><p style="text-align:center">20</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.87%"><p style="text-align:center">Total</p></td> 
       <td class="acenter" width="33.24%"><p style="text-align:center">80</p></td> 
       <td class="acenter" width="32.89%"><p style="text-align:center">100</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>AMC: amoxicillin/clavulanic acid, AMX: amoxicillin, TIC: ticarcillin, FOX: cefoxitin, CAZ: ceftazidime, FEP: cefepime, GMN: gentamycin, AKM: amikacin, SXT: trimethoprim/sulfamethoxazole, TET: tetracycline, NAL: nalidixic acid and ENRO: enrofloxacin.<xref ref-type="bibr" rid="scirp.145609-"></xref>Figure 2. Antibiotic resistance rates of Escherichia coli strains isolated from bovine faeces.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2260702-rId14.jpeg?20250915043359" />
    </fig>
   </sec>
   <sec id="s3_4">
    <title>3.4. Extended Spectrum Beta-Lactamase (ESBL)-Producing Strains of Escherichia coli</title>
    <p>Of the 80 strains of Escherichia coli isolated from bovine faeces, no strain was categorized as producing Extended Spectrum Beta-lactamase (ESBL) based on the detection of double synergy. However, the results reveal that the bacteria expressed resistance to one or more antibiotics (<xref ref-type="table" rid="table2">
      Table 2
     </xref>).</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.145609-"></xref>Table 2. Multidrug resistance in Escherichia coli strains isolated from bovine faeces.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="48.73%"><p style="text-align:center">Multi-resistance of isolated bacteria</p></td> 
       <td class="custom-bottom-td acenter" width="32.26%"><p style="text-align:center">Number of Bacterial Strains (n)</p></td> 
       <td class="custom-bottom-td acenter" width="19.01%"><p style="text-align:center">Percentage (%)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="48.73%"><p style="text-align:center">AMX</p></td> 
       <td class="custom-top-td acenter" width="32.26%"><p style="text-align:center">8</p></td> 
       <td class="custom-top-td acenter" width="19.01%"><p style="text-align:center">10</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="48.73%"><p style="text-align:center">AMC/NAL</p></td> 
       <td class="acenter" width="32.26%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="19.01%"><p style="text-align:center">10</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="48.73%"><p style="text-align:center">AMC/SXT/TET</p></td> 
       <td class="acenter" width="32.26%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="19.01%"><p style="text-align:center">10</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="48.73%"><p style="text-align:center">AMC/FEP/NAL/ENRO</p><p style="text-align:center">AMX/SXT/NAL/ENRO</p><p style="text-align:center">AMC/SXT/TET/NAL</p></td> 
       <td class="acenter" width="32.26%"><p style="text-align:center">24</p></td> 
       <td class="acenter" width="19.01%"><p style="text-align:center">30</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="48.73%"><p style="text-align:center">AMC/SXT/TET/NAL/ENRO</p></td> 
       <td class="acenter" width="32.26%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="19.01%"><p style="text-align:center">10</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="48.73%"><p style="text-align:center">AMC/FEP/SXT/TET/NAL/ENRO</p><p style="text-align:center">AMC/FOX/FEP/SXT/NAL/ENRO</p></td> 
       <td class="acenter" width="32.26%"><p style="text-align:center">16</p></td> 
       <td class="acenter" width="19.01%"><p style="text-align:center">20</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="48.73%"><p style="text-align:center">AMX/AMC/FOX/FEP/SXT/NAL/ENRO</p></td> 
       <td class="custom-bottom-td acenter" width="32.26%"><p style="text-align:center">8</p></td> 
       <td class="custom-bottom-td acenter" width="19.01%"><p style="text-align:center">10</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="48.73%"><p style="text-align:center">TOTAL</p></td> 
       <td class="custom-top-td acenter" width="32.26%"><p style="text-align:center">80</p></td> 
       <td class="custom-top-td acenter" width="19.01%"><p style="text-align:center">100</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>AMX = amoxicillin; AMC = amoxicillin + clavulanic acid; FEP = cefepime; SXT = trimethoprim + sulfamethoxazole; TET = tetracycline; FOX = cefoxitin; NAL = nalidixic acid; ENRO = enrofloxacin.</p>
   </sec>
   <sec id="s3_5">
    <title>3.5. Multi-Resistance of Escherichia coli Strains to the Antibiotics Tested</title>
    <p>The results in <xref ref-type="table" rid="table2">
      Table 2
     </xref> show that 8 strains of E. coli (10%) showed resistance to only one antibiotic (amoxicillin), while the majority of strains (90%) developed resistance to at least 2 antibiotics. In addition, this multi-resistance has affected several families of antibiotics (penicillins, cephalosporins, quinolones and fluoroquinolones, tetracyclines, other antibiotics such as the combination of trimethoprim + sulfamethoxazole).</p>
    <p>In <xref ref-type="table" rid="table3">
      Table 3
     </xref>, the results obtained showed that 70% of the strains showed resistance to at least three (3) families of antibiotics and 20% to at least four (4) families of antibiotics. The families of antibiotics concerned are beta-lactams, sulfonamides and cyclins.</p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.145609-"></xref>Table 3. Distribution of Escherichia coli strains resistant to several families of antibiotics.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="20.34%"><p style="text-align:center">Number of inactive antibiotic families</p></td> 
       <td class="custom-bottom-td acenter" width="42.30%"><p style="text-align:center">Families</p></td> 
       <td class="custom-bottom-td acenter" width="26.53%"><p style="text-align:center">Molecules</p></td> 
       <td class="custom-bottom-td acenter" width="10.83%"><p style="text-align:center">Number (%) (N = 80)</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="20.34%"><p style="text-align:center">One family</p></td> 
       <td class="custom-top-td acenter" width="42.30%"><p style="text-align:center">Beta-Lactam</p></td> 
       <td class="custom-top-td acenter" width="26.53%"><p style="text-align:center">Amoxicillin</p></td> 
       <td class="custom-top-td acenter" width="10.83%"><p style="text-align:center">8 (10)</p></td> 
      </tr> 
      <tr> 
       <td rowspan="2" class="acenter" width="20.34%"><p style="text-align:center">Two families</p></td> 
       <td class="acenter" width="42.30%"><p style="text-align:center">Beta-lactam</p></td> 
       <td class="acenter" width="26.53%"><p style="text-align:center">Amoxicillin/Clavulanic Acid</p><p style="text-align:center">Cefepime</p></td> 
       <td class="acenter" width="10.83%"><p style="text-align:center">40 (50)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="42.30%"><p style="text-align:center">Quinolones/Fluoroquinolones</p></td> 
       <td class="acenter" width="26.53%"><p style="text-align:center">Nalidixic acid</p><p style="text-align:center">Enrofloxacin</p></td> 
       <td class="acenter" width="10.83%"><p style="text-align:center">48 (60)</p></td> 
      </tr> 
      <tr> 
       <td rowspan="2" class="acenter" width="20.34%"><p style="text-align:center">Three families</p></td> 
       <td class="acenter" width="42.30%"><p style="text-align:center">Beta-lactams-Sulfonamides-Cyclins</p></td> 
       <td class="acenter" width="26.53%"><p style="text-align:center">Amoxicillin/Clavulanic Acid</p><p style="text-align:center">Sulfamethoxazole/Trimethoprim Tetracycline</p></td> 
       <td class="acenter" width="10.83%"><p style="text-align:center">48 (60)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="42.30%"><p style="text-align:center">Beta-Lactams-Sulfonamides-Quinolones/Fluoroquinolones</p></td> 
       <td class="acenter" width="26.53%"><p style="text-align:center">Amoxicillin</p><p style="text-align:center">Amoxicillin/Clavulanic Acid</p><p style="text-align:center">Cefoxitin</p><p style="text-align:center">Cefepime</p><p style="text-align:center">Sulfamethoxazole/Trimethoprim</p><p style="text-align:center">Nalidixic acid</p><p style="text-align:center">Enrofloxacin</p></td> 
       <td class="acenter" width="10.83%"><p style="text-align:center">8 (10)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="20.34%"><p style="text-align:center">Four families</p></td> 
       <td class="acenter" width="42.30%"><p style="text-align:center">Beta-Lactams-Sulfonamides-Cyclins-Quinolones/Fluoroquinolones</p></td> 
       <td class="acenter" width="26.53%"><p style="text-align:center">Amoxicillin/Clavulanic Acid</p><p style="text-align:center">Cefepime</p><p style="text-align:center">Sulfamethoxazole/Trimethoprim</p><p style="text-align:center">Tetracycline</p><p style="text-align:center">Nalidixic acid</p><p style="text-align:center">Enrofloxacin</p></td> 
       <td class="acenter" width="10.83%"><p style="text-align:center">16 (20)</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>The strains of Escherichia coli isolated from bovine faeces have been isolated in 23.80% of the levies. A lower prevalence (5.38%) was reported respectively by <xref ref-type="bibr" rid="scirp.145609-14">
     [14]
    </xref> and by Kayantao and al. <xref ref-type="bibr" rid="scirp.145609-15">
     [15]
    </xref> in Mali (8.28%). Nevertheless Oubayyou et al. reported a similar value (21.55%) in Niger <xref ref-type="bibr" rid="scirp.145609-16">
     [16]
    </xref>. However, all these results are lower than the one reported by Ouédraogo et al. in 2010 in Ouagadougou (29.2%) <xref ref-type="bibr" rid="scirp.145609-17">
     [17]
    </xref> and by Horo et al. in 2004 in Abidjan (31.92%) <xref ref-type="bibr" rid="scirp.145609-18">
     [18]
    </xref>. According to studies, bacterium Escherichia coli is a commensal of the digestive tract of humans and many animals, it represents the dominant species of the aerobic bacterial forest in the natural digestive flora of the intestine <xref ref-type="bibr" rid="scirp.145609-19">
     [19]
    </xref> <xref ref-type="bibr" rid="scirp.145609-20">
     [20]
    </xref>, which would explain its high prevalence in animals.</p>
   <p>Concerning beta-lactams, our study shows a resistance of 33.3% to amoxicillin, 30% for the combination amoxicillin/clavulanic acid, 16.70% to cefoxitin and 20% to cefepime, while ticarcillin and ceftazidime were found to be sensitive for all strains tested Probably because these molecules are not commonly used in veterinary medicine. Gay’s work on E coli from diarrhoea and mastitis in cows with regard to amoxicillin give levels of 85% and 30% respectively; The author explains that the differences can be observed depending on the bovine pathologies considered <xref ref-type="bibr" rid="scirp.145609-21">
     [21]
    </xref>. As for amoxicillin-clavulanate, the rate of 30% is well above the Roussel results for strains isolated from gastrointestinal samples (3.2%) <xref ref-type="bibr" rid="scirp.145609-22">
     [22]
    </xref>. Most commonly, clavulanic acid is not sufficient to restore sensitivity to amoxicillin in penicillinase-producing Enterobacteriaceae <xref ref-type="bibr" rid="scirp.145609-23">
     [23]
    </xref>. Indeed, this resistance to amoxicillin + clavulanic acid allows us to hypothesize a decrease in the activity of beta-lactamase inhibitors probably due either to an overproduction of penicillinases or to the inactivation of the inhibitor itself <xref ref-type="bibr" rid="scirp.145609-24">
     [24]
    </xref> . However, some strains of Escherichia coli were suspected of producing cephalosporinase with cefoxitin (16.70%) and cefepime (20%), contrary to Perrin’s results in 2021 which indicate a level of 0.3 to 0.6 in beef <xref ref-type="bibr" rid="scirp.145609-26">
     [26]
    </xref>. According to the same author, the percentage of Escherichia coli producer of β-Extended-spectrum lactamases (ESBLs) or cephalosporinases (ESBLs/AmpCs) are low, especially in foodstuffs. Some enzymes that hydrolyze broad-spectrum cephalosporins are thought to have initially derived from plasmid narrow-spectrum penicillinases and were mainly found in hospital strains <xref ref-type="bibr" rid="scirp.145609-27">
     [27]
    </xref>.</p>
   <p>
    <xref ref-type="bibr" rid="scirp.145609-"></xref>In the case of quinolones and fluoroquinolones, resistance rates vary according to the pathologies <xref ref-type="bibr" rid="scirp.145609-21">
     [21]
    </xref>. The Results in this study show that strains of Escherichia coli Isolated were resistant to 42.9% to nalidixic acid and 25% to enrofloxacin, A similar study shows resistance to nalidixic acid 17.9%, norfloxacin 11.3% and ciprofloxacin 10.6% for strains isolated from gastrointestinal specimens <xref ref-type="bibr" rid="scirp.145609-">
     [
    </xref><xref ref-type="bibr" rid="scirp.145609-22">
     22]
    </xref>.</p>
   <p>All strains in this study were sensitive to aminoglycosides, as indicated by the work in 2025 <xref ref-type="bibr" rid="scirp.145609-28">
     [28]
    </xref>, but a study carried out in Morocco in 2006 showed resistance of 16.7% for gentamicin and 12.6% for amikacin <xref ref-type="bibr" rid="scirp.145609-29">
     [29]
    </xref>.</p>
   <p>The percentages of resistance to tetracycline and trimethoprim-sulfamethoxazole were 10% and 20%, respectively, while Gay in 2008 found higher percentages in Escherichia coli for the combination of trimethoprim-sulfonamides (64%) and tetracycline (83%) (Gay et al., 2008).</p>
   <p>The results of this study show multidrug resistance in Escherichia coli isolated from bovine faeces to two families, three families, or even four families of antibiotics with levels ranging from 50 to 60% (see <xref ref-type="table" rid="table3">
     Table 3
    </xref>). This rate is well above the results of Résapath in 2020 <xref ref-type="bibr" rid="scirp.145609-30">
     [30]
    </xref> showing higher percentages of multidrug-resistant strains (MDR) among isolates from cattle (15%) compared to rates found in other animals (swine, poultry, companion animals). Resistance patterns highlight disparities between animal species and disease context within the same species, with 18% of bovine isolates from Escherichia coli are MDRs among strains isolated in digestive pathology, compared to only 3% for isolated strains of mastitis <xref ref-type="bibr" rid="scirp.145609-31">
     [31]
    </xref>. According to this author, resistance carried by plasmids can be transferred from one strain to another or from one bacterial species to another, thus accelerating their spread. The accumulation of resistance mechanisms in a bacterium can lead to therapeutic dead ends.</p>
   <p>In general, the antibiotic resistance of Escherichia coli strains isolated from bovine faeces was high for nalidixic acid, an antibiotic molecule against which most bacterial strains showed a higher resistance (42.9%). Resistance of less than 20% on the strains tested was found, to tetracycline, cefepime, cefoxitin, tetracycline and trimethoprim-sulfamethoxazole. The low rate of resistance observed in our study should not mask the current emergence of antibiotic resistance in Côte d’Ivoire <xref ref-type="bibr" rid="scirp.145609-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.145609-32">
     [32]
    </xref> <xref ref-type="bibr" rid="scirp.145609-33">
     [33]
    </xref>. Several studies showed intestinal microbiota to be a reservoir of antimicrobial resistant bacteria <xref ref-type="bibr" rid="scirp.145609-34">
     [34]
    </xref> <xref ref-type="bibr" rid="scirp.145609-35">
     [35]
    </xref>.</p>
   <p>Studies show that a bacterial strain can be resistant to several antibiotic families simultaneously (multidrug-resistant) and that the use of one antibiotic will co-select resistance to other antibiotic families, thus helping to enrich the bacterial population with multidrug-resistant strains <xref ref-type="bibr" rid="scirp.145609-36">
     [36]
    </xref>.</p>
   <p>The prevalence of Escherichia coli detected could highlight the need for further surveillance to identify critical points of contamination. In addition, the resistance rates of strains resistant to several antibiotics indicate that cattle may have been exposed to the inappropriate or excessive use of antibiotics and are an important reservoir of antibiotic-resistant bacteria acting as a means of spread.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>This study revealed the presence of Escherichia coli in cattle farms intended for human consumption. A high prevalence of BMR has been observed and resistance has affected the families of antibiotics most often used in human therapeutics, such as beta-lactams, fluoroquinolones and in chemoprophylaxis, particularly in people living with HIV such as cotrimoxazole.</p>
   <p>Nowadays, the gut microbiota is recognized as the place where many antibiotic-resistant bacteria emerge, multiply and spread within a population, making it a key player in the proliferation of antibiotic-resistant infections. Contamination of the environment by these germs can lead to the transmission of infectious diseases but also of bacteria carrying genes of resistance to humans from infected faeces present in the environment, in meat and milk, but also contamination by direct contact between humans and animals and also between animals.</p>
  </sec><sec id="s6">
   <title>6. Limitations of the Study</title>
   <p>This preliminary study can be improved by a larger sample size. However, these results clearly show the public health problem that resistant bacteria represent in animal health.</p>
  </sec><sec id="s7">
   <title>Financing</title>
   <p>The work of this study was carried out with institutional funding.</p>
  </sec><sec id="s8">
   <title>Acknowledgements</title>
   <p>We would like to thank the Observatory of Microorganism Resistance to Anti-Infectives for Côte d’Ivoire (ORMICI) as well as the Antibiotics, Natural Substances and Surveillance of Microorganism Resistance to Anti-Infectives Unit (ASSURMI) of the Institut Pasteur de Côte d’Ivoire for its technical support in carrying out this study.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.145609-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yao, K.R. (2019) Caracterisation phenotypique et moleculaire de salmonella sp et Escherichia coli isolees chez les bovins dans le district d’abidjan (côte d’Ivoire): Im-pact biologique de l’utilisation des antibiotiques. Ph.D. Thesis, Université Félix Hou-phouêt-Boigny. &gt;https://hal.science/tel-02405713 
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     FAO (2016) Contribution de l’élevage à la sécurité alimentaire dans la région Proche-Orient et Afrique du Nord. &gt;https://www.fao.org/family-farming/detail/fr/c/897883/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kouassi, A., Aké-Assi, E., N’goran, K.B., Ouattara, D. and Tiébré, M. (2019) Contribution de l’élevage urbain à la sécurité alimentaire: Stratégies d’adaptation des éleveurs de bovins dans le District d’Abidjan, Côte d’Ivoire. Afrique Science, 15, 218-228. &gt;https://www.researchgate.net/publication/340279824 
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Paterson, D.L. (2006) Resistance in Gram-Negative Bacteria: Enterobacteriaceae. The American Journal of Medicine, 119, S20-S28. &gt;https://doi.org/10.1016/j.amjmed.2006.03.013
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sanders, P., Bousquet-Melou, A., Chauvin, C. and Toutain, P.L. (2011) Utilisation des antibiotiques en élevage et enjeux de santé publique. INRAE Productions Animales, 24, 199-204. &gt;https://doi.org/10.20870/productions-animales.2011.24.2.3254
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sanders, P., Perrin-Guyomard, A. and Moulin, G. (2017) Évolution de l’utilisation des antibiotiques en production animale. Cahiers de Nutrition et de Diététique, 52, 301-311. &gt;https://doi.org/10.1016/j.cnd.2017.06.002
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Moubareck, C., Bourgeois, N. and Doucet‐Populaire, F. (2003) L’utilisation des antibi-otiques en pratique vétérinaire et ses risques pour la santé humaine. Environnement, Risques&amp;Santé, 2, 97-104.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Van Boeckel, T.P., Brower, C., Gilbert, M., Grenfell, B.T., Levin, S.A., Robinson, T.P., et al. (2015) Global Trends in Antimicrobial Use in Food Animals. Proceedings of the National Academy of Sciences of the United States of America, 112, 5649-5654. &gt;https://doi.org/10.1073/pnas.1503141112
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cabrera González, M.A., Vásquez Pérez, H.V., Quilcate-Pairazamán, C., Bazán-Arce, J. and Cueva-Rodríguez, M. (2023) Evaluación de resistencia a antibióticos en muestras de heces de terneros con diarrea en la región Cajamarca, Perú. Revista Mexicana de Ciencias Pecuarias, 14, 782-795. &gt;https://doi.org/10.22319/rmcp.v14i4.6354
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     ONU (2023) ONU-Habitat Côte d’Ivoire Rapport Pays.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kouao, J., Tagnon, B.O., Koffi, B., Kouassi, A.M., Kouassi, K.A. and Gone, D.L. (2024) Variabilité et tendances interannuelles du climat à l’échelle de la Côte d’Ivoire sur la période 1961-2016. European Scientific Journal, ESJ, 20, 218-240. &gt;https://doi.org/10.19044/esj.2024.v20n33p218
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Théophile, M.K., Archippe, B.M., David, L.M., Mihuhi, N., Mutendela, J.K. and Kanigula, M. (2018) Antibio-résistance des souches de Salmonella ssp isolées des hémocultures à Bukavu en RD Congo. Pan African Medical Journal, 29, Article 42. &gt;https://doi.org/10.11604/pamj.2018.29.42.13456
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Drieux, L., Brossier, F., Sougakoff, W. and Jarlier, V. (2008) Phenotypic Detection of Extended-Spectrum β-Lactamase Production in Enterobacteriaceae: Review and Bench Guide. Clinical Microbiology and Infection, 14, 90-103. &gt;https://doi.org/10.1111/j.1469-0691.2007.01846.x
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Coulibaly, Y., Goita, D., Dicko, H., Keita, M., Doumbia, D. and Diallo, A. (2012) Césarienne en urgence au CHU du Point G: Évaluation de la prise en charge anesthésique. Revue Africaine d’anesthésiologie et de Médecine d’Urgence (RAMUR), No. 4, 11.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kayantao, D., et al. (2001) Aspects épidémiologiques, cliniques et évolutifs des pneumopathies bactériennes à l’hôpital du point G à Bamako. Médecine d’Afrique Noire, 48, 427-431.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Oubayyou, A.M., Moumouni, H., Zida, A., Gagara Issoufou, M.A. and Traore, A.S. (2018) Bacilles Gram négatifs isolées à l’examen des prélèvements pulmonaires en milieu hospitalier à Niamey (Niger): Recherche épidémiologique et thérapeutique. International Journal of Biological and Chemical Sciences, 11, 2713-2729. &gt;https://doi.org/10.4314/ijbcs.v11i6.13
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ouédraogo, S.M., et al. (2010) Aspects Epidemio-cliniques des Pneumopathies AI-guës Bacteriennes de L’Adulte au Chu Yalgado Ouedraogo. Mali Médical, 25, 15-18.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Horo, K., Boko Kouassi, A., N’goran Koffi, B., Severin N’gom, A., Kamdem Kenmogne, F. and Aka-Danguy, E. (2004) 153 Facteurs de décès précoce par Pneumopathie Aiguë Communautaire (PAC) en milieu africain. Revue des Maladies Respiratoires, 21, 69. &gt;https://doi.org/10.1016/s0761-8425(04)71779-9
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cohen, N. and Karib, H. (2006) Risque hygiénique lié à la présence des Escherichia coli dans les viandes et les produits carnés: Un réel problème de santé publique? Les Technologies de Laboratoire, 1, 4-9.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Massot, M., Picard, B. and Denamur, E. (2016) Diversité des populations d’Escherichia coli et leurs variations au cours du temps au sein du microbiote intestinal. Revue Francophone des Laboratoires, 2016, 35-43. &gt;https://doi.org/10.1016/s1773-035x(16)30326-4
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gay, É., et al. (2008) Apport du Résapath à la problématique de l’antibiorésistance en santé animale: Analyse des données recueillies en 2008 sur Escherichia coli dans les différentes filières animals. Bulletin Epidémiologique, 36, 6-9.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roussel-Delvallez, M., Caillaux, M., Cattöen, C., Decoster, A., Descamps, D., Graveline, N., et al. (2007) Prévalence de la résistance d’Escherichia coli isolés de prélèvements d’origine urinaire ou gastro-intestinale vis-à-vis de l’association amoxicilline-acide clavulanique et de divers antibiotiques. Antibiotiques, 9, 65-69. &gt;https://doi.org/10.1016/s1294-5501(07)88769-3
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Koeck, J.L., Cavallo, J.D., Fabre, R., Meyran, M. and Roué, R. (1996) [Antibiotic Sensitivity of Aerobic Gram-Negative Bacilli Isolated from Severe Infections in 1992: Results of a French Multicenter Study. Groupe d’Etude d’Infections à bacilles à Gram Né-gatif (GEIGN)]. Presse medicale (Paris, France: 1983), 25, 1363-1366.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kamga, H.G., Nzengang, R., Toukam, M., Sando, Z. and Shiro, S.K. (2014) Phénotypes de résistance des souches d’Escherichia coli responsables des infections urinaires communautaires dans la ville de Yaoundé (Cameroun). African Journal of Pathology and Microbiology, 3, 1-4. &gt;https://doi.org/10.4303/ajpm/235891
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Diendere, A., et al., (2019) Résistance aux antibiotiques des souches de staphylococcus aureus et des enterobactéries isolés au LNSP de Ouagadougou (Burkina Faso). Sciences De La Santé, 42, 83-94.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Perrin-Guyomard, A., Kempf, I., Adam, C. and Granier, S. (2021) Prévalence des Escherichia coli résistants aux céphalosporines de troisième génération ou aux car-bapénèmes dans les viandes fraiches a la distribution en France. Bulletin Épidémiologique, 1-9.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ouedraogo, A.S. (2016) Prévalence, circulation et caractérisation des bactéries mul-tirésistantes au Burkina Faso. Ph.D. Thesis, Université Montpellier. &gt;https://theses.hal.science/tel-01476152 
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ugbo, E., Effendi, M., Ugbo, A., Tyasningsih, W., Agumah, B., Raharjo, H., et al. (2025) Molecular Identification of Tetracycline Resistance Genes in Escherichia coli Isolates from Internal Organs of Swine Sold on Abakaliki, Nigeria. Open Veterinary Journal, 15, 171-178. &gt;https://doi.org/10.5455/ovj.2025.v15.i1.16
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Davido, B. (2010) Etude de la prise en charge ambulatoire des infections cutanées communautaires à staphylocoque doré. Université Denis Diderot Paris 7.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     ANSES (2020) Réseau d’épidémiosurveillance de l’antibiorésistance des bactéries pathogènes animales, Bilan 2020.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref31">
    <label>31</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Madec, J. (2023) Antibiorésistance chez l’animal en France: Quels résultats? INRAE Productions Animales, 35, 275-292. &gt;https://doi.org/10.20870/productions-animales.2022.35.4.7284
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref32">
    <label>32</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Assoumy, M.A., Bedekelabou, A.P., Teko-Agbo, A., Ossebi, W., Akoda, K., Nimbona, F., et al. (2021) Antibiotic Resistance of Escherichia coli and Salmonella Spp. Strains Isolated from Healthy Poultry Farms in the Districts of Abidjan and Agnibilékrou (côte d’Ivoire). Veterinary World, 14, 1020-1027. &gt;https://doi.org/10.14202/vetworld.2021.1020-1027
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref33">
    <label>33</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Guessennd, N., Ouattara, M., Ouattara, N., Nevry, R., Gbanon, V., Tiekoura, K., et al. (2013) Étude des bactéries multirésistantes des effluents hospitaliers d’un centre hospitalier et universitaire (CHU) de la ville d’Abidjan (Côte d’Ivoire). Journal of Applied Biosciences, 69, 5456-5464. &gt;https://doi.org/10.4314/jab.v69i0.95071
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref34">
    <label>34</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     INSERM (2021) Microbiote intestinal (flore intestinale) · Inserm, La science pour la santé, Inserm. &gt;https://www.inserm.fr/dossier/microbiote-intestinal-flore-intestinale/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref35">
    <label>35</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pilmis, B. (2021) Impact des Antibiotiques sur le microbiote digestif et l’émergence de bactéries multirésistantes. Master’s Thesis, Université Paris-Saclay.
    </mixed-citation>
   </ref>
   <ref id="scirp.145609-ref36">
    <label>36</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Webb, H.E., Granier, S.A., Marault, M., Millemann, Y., den Bakker, H.C., Nightingale, K.K., et al. (2016) Dissemination of the MCR-1 Colistin Resistance Gene. The Lancet Infectious Diseases, 16, 144-145. &gt;https://doi.org/10.1016/s1473-3099(15)00538-1
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>